Skip to content
1M1B Changemakers
  • Home
  • 1M1B
    • Flaunch
    • Hypershift
  • Changemakers
  • Blogs
    • Trending
    • Impact
  • Contact Us
  • Toggle website search
Menu Close
  • Home
  • 1M1B
  • Flaunch
  • Hypershift
  • Changemakers
  • Blogs
  • Trending
  • Impact
  • Contact Us

Rituximab biosimilar

  1. Home>
  2. Blog>
  3. Rituximab biosimilar
Dr Reddy’s Rituximab biosimilar Ituxredi gets EMA CHMP positive recommendation – Times of India

Dr Reddy’s Rituximab biosimilar Ituxredi gets EMA CHMP positive recommendation – Times of India

  • Post author:1m1bchangemakers
  • Post published:July 29, 2024
  • Post category:Business
  • Post comments:0 Comments

HYDERABAD: Pharma biggie Dr Reddy’s Laboratories Ltd on Monday said the European Medicines Agency’s (EMA) committee for medicinal products for human use (CHMP) has recommended its proposed Rituximab biosimilar candidate…

Continue ReadingDr Reddy’s Rituximab biosimilar Ituxredi gets EMA CHMP positive recommendation – Times of India

Trending Category

  • Blogs
  • Business
  • Education
  • Top Stories
  • Trending

Recent Posts

  • Industrial property developer Soon Hock Enterprise opens 8.6% above IPO price in mainboard debut
  • Ontario defends controversial residency rules for international medical graduates despite criticism – The Times of India
  • Galeries Lafayette sets foot in India with Mumbai store – The Times of India
  • ‘Old’ is gold this wedding season – The Times of India
  • After MIT, Brown University rejects Trump’s funding deal over academic freedom concerns: Should universities sacrifice autonomy for financial gain? – The Times of India
All rights reserved © 2023 1M1B.